Hemolytic anemia with thrombocytopenia and organ damage raises suspicion for thrombotic microangiopathy (TMA), a pathology that results in thrombosis within the small vessels secondary to endothelial injury. While usually attributed to atypical hemolytic uremic syndrome (aHUS) or thrombotic thrombocytopenic purpura (TTP), an increasingly recognized and treatable entity is pseudo-thrombotic microangiopathic anemia (pseudo-TMA) secondary to severe vitamin B-12 deficiency.While TMA often requires expensive diagnostic testing and can lead to invasive treatment options such as plasma exchange, immunosuppression, and/or complement cascade blocking, pseudo-TMA requires only vitamin supplementation. Therefore, the prompt and accurate diagnosis of this entity is important for the clinician to recognize in order to avoid unnecessary health costs and institute appropriate treatment.We present the case of a 51-year-old male without any past medical history, who presented with generalized weakness, dyspnea on exertion, and decreased exercise tolerance for several months and was found to have severe microangiopathic anemia with work-up concerning for TTP. After stabilization, he was found to have severe B-12 deficiency secondary to newly diagnosed pernicious anemia and was treated with subcutaneous B-12 injections with improvement in clinical symptoms and laboratory parameters. This presentation highlights the need for prompt diagnosis and high clinical suspicion for vitamin deficiencies as a source of pseudo-microangiopathy.

Cardiac arrest is a life-threatening condition with low survival rate. Over the years ACLS guidelines have been developed to reduce cardiac arrest specific mortality rate. In this review article, the authors researched steroid use during and after CPR for determining its effect on survival rate and post cardiac arrest disabilities. Scholarly articles from well-known reputed journals relevant to both cardiac arrest and steroid use since 1960 have been reviewed. This article first examines the question whether cardiac arrest can be considered an inflammatory state. Afterwards, evidence of the beneficial role of steroid use in cardiac arrest and in other cardiac conditions have been outlined. In conclusion, this review paper summarizes any benefits of steroid use in cardiac arrest.Bangladesh Crit Care J September 2018; 6(2): 92-94